The word 'compliance' comes from the Latin word complire, meaning to fill up and hence to complete an action, transaction, or process and to fulfill a promise. In the Oxford English Dictionary, the relevant definition is 'The acting in accordance with, or the yielding to a desire, request, condition, direction, etc.; a consenting to act in conformity with; an acceding to; practical assent". Compliance with therapy is simply patients understanding of medication; motivation toward having this medication is a prescribed manner with the belief that the prescriber and prescribed medicine will be beneficial for his well-being. Although this is often the case, in a number of situations, the physician and pharmacist have not provided the patient with adequate instructions or have not presented the instructions in such a manner that the patient understands them. Nothing should be taken for granted regarding the patient's understanding of how to use medication, and appropriate steps must be taken to provide patients with the information and counseling necessary to use their medications as effectively and as safely as possible. 20% to 30% of new prescriptions are never filled at the pharmacy. Medication is not taken as prescribed 50% of the time. For patients prescribed medications for chronic diseases, after six months, the majority take less medication than prescribed or stop the medication altogether. There are both federal and state laws that make using or sharing prescription drugs illegal. If someone take a pill that was prescribed to someone else or give that pill to another person, not only is it against the law, it's extremely dangerous.
INTRODUCTION
According to the WHO, lack of adherence to medical treatment regimen gives rise to major clinical problems in patients, mostly with chronic illness. Rates of nonadherence with any medication treatment varies from 15% to 93%, with an average estimated rate of 50% worldwide. "Drugs don't work if people don't take them." This observation made by former Surgeon General C Everett Koop in his keynote address at a symposium on Improving Medication Compliance, provides a clear statement of one of the consequences of noncompliance. In many cases noncompliance results in underuse of a drug, thereby depriving the patient of the anticipated therapeutic benefits and possibly resulting in a progressive Medication nonadherence for patients with chronic diseases is extremely common, affecting as many as 40% to 50% of patients who are prescribed medications for management of chronic conditions such as diabetes or hypertension. This nonadherence to prescribed treatment is thought to cause at least 100,000 preventable deaths and $100 billion in preventable medical costs per year. Despite this, the medical profession largely ignores medication nonadherence or sees it as a patient problem and not a physician or health system problem. A recent BMJ study shows annual costing of medication non-adherence range from USD 100 to USD 290 billion in USA, €1.25 billion in Europe and approximately $A7 billion in Australia. Along with staggering economic losses, patient compliance also presents a major hurdle to patient health. For instance, compliance rates below 90% for HIV patients can cause viral replication and disease progression while for diabetics, proper compliance is essential in preventing hypertension and myocardial infarction. Adherence consists of 3 essential factors:
A. Patient: Takes treatment decision process by their own, based on individual literacy and feedback from others, mostly nonprofessionals.
DIMENSIONS OF PATIENT MEDICATION ADHERENCE
Adherence is a multidimensional phenomenon determined by the interaction of five sets of factors--termed "dimensions" by the WHO. with the health system) (Subbaraman et.al., 2018) . Studies have found that patients' beliefs about medicines and their perception of their illness contribute towards poor adherence (Kumar et.al., 2016) . Worldwide, between 25% and 50% of patients do not take their medications as recommended. In the USA, suboptimal adherence has been associated with 125,000 deaths, 10% of hospitalizations, and costs 300 billion USD annually (Zullig et.al., 2018) . The economic impact was also in PubMed and Scopus in September 2017, which shows an increase in total healthcare cost (>80%), pharmacy costs (70%), inpatient and outpatient costs (50%), emergency department visit and medication costs (<30%), and hospitalization costs (<20%) (Cutler et.al., 2018) . Nearly 70% of all medication-related hospital admissions are due to medication nonadherence alone (Kuo et.al., 2016) . Across South Asia, overall hypertension prevalence is estimated to be 27%. Prospective Urban Rural Epidemiology study has shown more than 50% are unaware of it and up to 80% of hypertensive patients have low adherence to medication (Naheed et.al., 2018 , 2018) . In a study conducted among people with diabetes only 30% were compliant with drug regimens and the non-compliance was higher among the lower socioeconomic groups (Shrivastava et.al., 2013) .
Non-patient Factors associated with Non-adherence  The nature of patient illness  Therapeutic regime  Treatment duration  Frequency of drug administration  Adverse events  Taste of medication
Patient Non-Compliance
Non-compliance with drug treatment is widespread. When patients are given medication by their doctors, nearly half do not take the drug or do not take it as prescribed, and most will stop the treatment as soon as they are feeling better. A major problem in identifying the non-compliant patient is the unreliability of many of the measures used for assessing compliance. There are few social and demographic characteristics associated with noncompliance. The type of disease, also, generally has little influence on the level of compliance. Psychological factors such as the patients' levels of anxiety, motivation to recover, attitudes towards their illness, the drug and the doctor, as well as the attitudes and beliefs of significant others in their environment do influence the patients' levels of compliance (Evans et.al., 1983) . One of the more compelling rationales offered for expanding drug coverage is that affordability problems have clinical as well as economic consequences; that is, patients who have difficulty paying for medications are less likely to take them and can suffer adverse health effects as a result of noncompliance (Kennedy et.al., 2002) .
Types of Non-compliance
The situations most commonly associated with noncompliance with drug therapy include following situations:  Some patients for whom medication has been prescribed do not even take their prescriptions to a pharmacy, and some others who do take their prescriptions to a pharmacy fail to pick them up when they are completed.  The omission of doses is one of the most common types of noncompliance and occurs when a medication is to be administered at frequent intervals and/or for an extended period of time. tetracycline, alendronate (Fosamax)-should be administered apart from meals to achieve optimal absorption. The time of day at which a drug is administered also may be important in the use of some medications; e.g., diuretics are best administered in the morning.  The premature discontinuation of treatment occurs commonly with the use of antibiotics as well as medications used in the treatment of chronic disorders such as hypertension (Hussar, 2006) .
REASONS OF NON-COMPLIANCE IN ELDERLY PATIENTS
Currently the aging population is rapidly increasing, particularly in developing regions of the world, due to longer expectancy of life, better healthcare facilities and greater awareness about healthy lifestyle. Today, in developed countries, more than 75% die after the age of 75 years (Lunenfeld et.al., 2013) . Because of the progressively increasing geriatric population requiring special care, there is a growing global concern to improve the health care delivery systems, particularly against chronic and recurrent illnesses that occur more commonly during later life such as: diabetes mellitus, hypertension, IHD, arthritic disorders, neurodegenerative disorders, psychiatric illnesses, gastrointestinal disorders, ocular disorders, genitourinary disorders, respiratory disorders etc., which may require chronic medication with multiple drugs. Because of the chronic nature of the disease, the need for multiple drug therapy with complex medication regime, increasing cost of therapy, adverse effects, drug interactions, forgetfulness, lack of familial and social support and care, elderly patients may not be fully compliant to long term medications. In general, only 50% of general population has been estimated to adhere to their medications, and this may range from 47 to 100% in elderly. Poor compliance among older persons is a public health concern, as it accounts for adverse outcomes, medication wastage with increased cost of healthcare, and substantial worsening of the disease with increased disability or death (Shruthi et.al., 2016) . However, Notable Reasons behind elderly non-compliance issues are: 
CONSEQUENCES OF NON-COMPLIANCE
Physicians frequently do not effectively communicate to their patients about the basic information of treatment plans. Patients may be left with concerns about adverse effects and with lack of comprehension of disease and treatment that adversely affect their adherence. Framing the problem of poor adherence on patients' fear of side effects or lack of understanding does not clearly emphasize the physician's responsibility to appropriately address these concerns. The same hurdle can be reformulated as a problem of physicians' inadequate, ineffective communication to patients of critical information. This reformulation demonstrates that physicians have a responsibility to minimize barriers to non-compliance by changing that which physicians have control over patients' own behavior (Devine et.al., 2018) . Notable noncompliance results are: a) Underuse of a drug, deprives the patient of the anticipated therapeutic benefits and possibly resulting in a progressive worsening or other complications of the condition being treated e.g. underutilization and nonadherence of warfarin among nonvalvular AF patients is both prevalent and costly (Casciano et.al., 2013) . The statins significantly reduce morbidity and mortality in patients with CHD and in patients with hyperlipidemia, when they are used on a continuing basis (Rosuvastatin, up to 55% FACTORS ASSOCIATED WITH NON-COMPLIANCE Disease: Antipsychotic medication reduces the severity of serious mental illness (SMI), nonadherence to the treatment of SMI increases the risk of relapse and hospitalization. Poor insight was identified as a reason for nonadherence in more than 50% of studies, followed by a negative attitude toward medication in 30% and cognitive impairments in nearly 15% (Velligan et.al., 2017 Non-compliance Detection--Current detection methods include indirect measures, such as selfreport, interview, therapeutic outcome, pill count, change in the weight of metered-dose inhaler canisters, medication-refill rate, insurance prescription claims databases, and computerized compliance monitors, and direct measures, such as biological markers, tracer compounds, and assay of body fluids. In general, the direct methods of detection have a higher sensitivity and specificity than the indirect methods. However, all of these methods have their limitations. To help overcome limitations of the assessment methods and to provide corroborative information, it is recommended that at least two different detection methods be used to measure compliance.
 Indirect Methods:
Self-reports and interviews with patients are the most common and simplest methods of attempting to determine compliance with therapy. Pill counts are another detection method used to measure compliance and frequently are used in clinical drug studies. A patient's compliance with a medication regimen can be assessed by the difference between the number of dosage units initially dispensed and the number remaining in the container on a return visit or during an unscheduled home visit. However, pill dumping (i.e., attempts by patients to misrepresent their compliance by discarding medication) is common, and several studies have shown that return counts grossly overestimate actual compliance rate. 
IMPROVING COMPLIANCE
Pharmacists have a particularly valuable opportunity to encourage compliance since their advice accompanies the actual dispensing of the medication, and they usually are the last health professional to see the patient prior to the time the medication is to be used. a) Identification of Risk Factors--These factors should be considered in planning the patient's therapy so that the simplest regimen that is, to the extent possible, compatible with the patient's normal activities can be developed. b) Development of Treatment Plan--The more complex the treatment regimen, the greater is the risk of noncompliance, and this must be recognized in the development of the treatment plan. that hospitalized patients be given the responsibility for self-medication prior to discharge. Usually, patients go from a complete dependence on others for the administration of their medication while hospitalized to a situation in which they are given the full responsibility when discharged, often with the assumption that they know about their drugs because they were taking them in the hospital. The suggested arrangement would permit patients to start using the medications on their own before discharge, so that health-care professionals can more directly identify problems or situations that might undermine compliance, and answer patient questions (Waring et.al., 2014 and Reinhard et.al., 2008) . h) Patient Motivation--Motivation is the driving force underlying the wish to change behavior. HCPs reported that EMMA supported patient-centered consultations in adults with type 2 diabetes by facilitating dialogue, reflection, and patient activity. The use of tools elicited patients' perspectives and facilitated patient participation and shared decision-making. After 2 months, nearly 60% participants stated that they followed the goal and plan to a high or very high extent (Varming et.al., 2015) .
COMPLIANCE AIDS Labeling:
The importance of the accuracy and specificity of the information on the label of the prescription container has been noted. Auxiliary labels that provide additional information regarding the use, precautions, and/or storage of the medication also will contribute to the attainment of compliance. The inclusion of pictograms in labeling and patient information leaflets has been demonstrated to have a positive effect in the acquisition and understanding of information regarding medications prescribed for patients with limited literacy skills.
Special Medication Calendars and Drug Reminder Charts:
Various forms, such as medication calendars, have been developed and are designed to assist patients in self-administering drugs. In addition to their use in helping patients understand which medication to take and when to take it, the forms on which patients are to check the appropriate area for each dose of medication they take, can be evaluated by the pharmacist or physician when the patients return for more medication or have their next appointment. An automatically generated reminder chart is a practical and cost-effective aid to compliance (Boeni et such packaging as a patient education tool has been published.  This type of packaging usually is based on blister packaging using unit-of-use dosing and is designed to serve as a patient-education tool for health professionals and to make it easier for patients to understand and remember to take their medications correctly at home. Specially designed packaging for oral contraceptives was one of the first initiatives of this type and has been valuable in increasing patient understanding of how these agents are to be taken.  Special packages of certain corticosteroids (eg.
Medrol Dosepak) also have been designed to facilitate the use of steroids in dosage regimens that may be difficult to understand or remember (Baptist Health, 2018)  The Medicine-On-Time system is an example of a packaging system that provides unit-of-use dosing with specific labeling in a plastic card that is set up like a calendar. In addition to simplifying the use of medications for patients who selfadminister their medications, these systems also have been very useful in the distribution and administration of medications in assisted living and other patient-care facilities (Bouvier, 2012).  A possible negative effect of drug packaging on patient compliance is seen with the use of the child-resistant containers. Some patients, particularly the elderly and those with conditions like arthritis, asthma and parkinsonism, have difficulty opening some of these containers and may not persist in their efforts to do so. There also may be difficulty opening some foil-packed drugs. Pharmacists should be alert to problems of this type and, when appropriate, suggest use of standard containers or caps (Ozturk et.al., 2016 ; National Research Council, 2010; New medical devices 2014) Dosage Forms: New dosage forms of certain drugs also have been developed, in large part in recognition of problems of noncompliance. For example, the development of longer-acting, controlled-release dosage forms of numerous medications (egg, calcium channel blocking agents) has permitted less frequent administration of these agents, which facilitates compliance. The use of transdermal delivery systems permits less-frequent administration of the drugs (egg, nitroglycerin, fentanyl) given by this route (Hussar, 2006) .
MONITORING THERAPY Self-Monitoring:
Patients should be apprised of the importance of monitoring their own treatment regimen and, in some situations, the response parameters. Pharmacist Monitoring: Since pharmacists and pharmacy staff frequently interact with their patients and establish strong pharmacist-to-patient relationships, they are uniquely positioned to address their patient's medication concerns and help improve adherence (Taitel et.al., 2017) . The pharmacist's role in minimizing noncompliance does not end when the prescription is dispensed. Pharmacist follow-up with telephoned or mailed refill reminders has been found to increase compliance. One approach in which both health professionals and patients have collaborated effectively in reviewing/monitoring the use of medication has been the brown bag program (Willeboordse et.al, 2014 and Köberlein-Neu et.al., 2016). The Administration on Aging and NCPIE have encouraged older consumers to put all their medicines in a bag and take them to their health professional for a personalized medicine review (Mohiuddin , 2018). DOT: A method of drug administration in which a health care professional watches as a person takes each dose of a medication. Directly observed therapy (DOT) is used to ensure the person receives and takes all medications as prescribed and to monitor response to treatment. With DOT, a patient meets with a health care worker every day or several times a week. The health care worker also asks the patient about any problems or side effects with the medication. DOT should be done at a time and place that is convenient for the patient. DOT is widely used to manage tuberculosis (TB) disease. In HIV treatment, DOT is sometimes called directly administered antiretroviral therapy (DAART) ( 
BENEFITS OF PATIENT COMPLIANCE
When patients experience chronic or acute episodes, many treatment options require patients to partake in lifestyle changes in order to address the root cause of their illness. The improvement of compliance will result in a situation in which all parties benefit. Most importantly patients benefit from the enhancement of the efficacy and safety of their drug therapy. Pharmacists benefit because there is an increased recognition and respect for the value of the advice and service that they provide. Pharmaceutical manufacturers benefit from the favorable recognition that accompanies the effective and safe use of their drugs as well as from the increased sales resulting from the larger number of prescriptions being dispensed. Finally, society and the health care system benefit as a result of fewer problems associated with noncompliance. Although an increase in compliance will result in more prescriptions being dispensed and a higher level of expenditures for prescription medications, this increase in costs will be more than offset by a reduction in costs (eg, physician visits, hospitalizations) attributable to problems due to noncompliance (Suri et 
